Zobrazeno 1 - 6
of 6
pro vyhledávání: '"D. Ucar-Bilyeu"'
Autor:
J. Stalinska, E. Zimolag, NA. Pianovich, A. Zapata, A. Lassak, M. Rak, M. Dean, D. Ucar-Bilyeu, D. Wyczechowska, F. Culicchia, L. Marrero, L. Del Valle, J. Sarkaria, F. Peruzzi, BS Jursic, K. Reiss
Publikováno v:
Translational Oncology, Vol 12, Iss 7, Pp 895-907 (2019)
Anticancer effects of a common lipid-lowering drug, fenofibrate, have been described in the literature for a quite some time; however, fenofibrate has not been used as a direct anticancer therapy. We have previously reported that fenofibrate in its u
Externí odkaz:
https://doaj.org/article/220dbf6545a74b5ab39ed2380a279119
Autor:
D Ucar-Bilyeu, Adriana Zapata, Jann N. Sarkaria, L. Del Valle, Francesca Peruzzi, Branko S. Jursic, Krzysztof Reiss, Adam Lassak, N A Pianovich, E Zimolag, Dorota Wyczechowska, Luis Marrero, J Stalinska, M. Dean, Frank Culicchia, Monika Rak
Publikováno v:
Translational Oncology, Vol 12, Iss 7, Pp 895-907 (2019)
Anticancer effects of a common lipid-lowering drug, fenofibrate, have been described in the literature for a quite some time; however, fenofibrate has not been used as a direct anticancer therapy. We have previously reported that fenofibrate in its u
Autor:
Van T. Hoang, Krzysztof Moroz, Elizabeth C. Martin, Nicholas C. Pashos, Alex Alfortish, Benjamen O’Donnell, Hope E. Burks, Steven D. Jones, Kristin S. Miller, Lucio Miele, Adam Riker, Ayse D. Ucar Bilyeu, Bruce A. Bunnell, Annie C. Bowles, Fokhrul Hossain, Margarite D. Matossian, Rachel A. Sabol, Bridgette M. Collins-Burow, Tiffany R. Chang, Arnold H. Zea, Matthew E. Burow
Publikováno v:
Molecular Cancer Research. 16:A01-A01
Triple-negative breast cancers (TNBCs) constitute approximately 12% of all breast cancers, and are approximately twice more prevalent in African-American populations. Louisiana has a high proportion of African-American residents (32.5% in 2015), and
Autor:
Ayse D. Ucar Bilyeu, Antonio Pannuti, Fokhrul Hossain, Claudia Sorrentino, Matthew E. Burow, Todd E. Golde, Margarite D. Matossian, Barbara A. Osborne, Lucio Miele, Judy S. Crabtree
Publikováno v:
Cancer Research. 78:157-157
Triple Negative Breast Cancer (TNBC), an aggressive, heterogeneous subtype of breast cancer, and immunohistochemically negative for estrogen receptor α (ER-), progesterone receptor (PR-), and lacking amplification of the human epidermal growth facto
Autor:
Lucio Miele, Judy S. Crabtree, Claudia Sorrentino, Ayse D. Ucar Bilyeu, Antonio Pannuti, Fokhrul Hossain, Todd E. Golde, Barbara A. Osborne
Publikováno v:
Cancer Research. 77:2904-2904
Triple negative breast cancer (TNBC) is a heterogeneous group of clinically aggressive diseases. TNBC patients have high risk of recurrence and metastasis, and current treatment options remain limited. Cancer stem-like cells (CSCs) have been linked t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.